Nxera Pharma
(OTC) SOLTF
Nxera Pharma Financials at a Glance
Market Cap
$492.29M
Revenue (TTM)
$29.72B
Net Income (TTM)
$12.56B
EPS (TTM)
$-0.92
P/E Ratio
-5.93
Dividend
$0.00
Beta (Volatility)
0.04 (Low)
Dividend
$0.00
Beta (Volatility)
0.04 (Low)
Price
$5.44
Volume
100
Open
$5.44
Price
$5.44
Volume
100
Open
$5.44
Previous Close
$5.44
Daily Range
$5.44 - $5.44
52-Week Range
$4.90 - $7.20
Dividend
$0.00
Beta (Volatility)
0.04 (Low)
Price
$5.44
Volume
100
Open
$5.44
Previous Close
$5.44
Daily Range
$5.44 - $5.44
52-Week Range
$4.90 - $7.20
SOLTF News
SOLTF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Nxera Pharma
Industry
Pharmaceuticals
Sector
Health CareEmployees
374
CEO
Chris Cargill
Website
www.nxera.lifeHeadquarters
Tokyo, 102-0083, JP
SOLTF Financials
Key Financial Metrics (TTM)
Gross Margin
72%
Operating Margin
-28%
Net Income Margin
-42%
Return on Equity
-20%
Return on Capital
-7%
Return on Assets
-9%
Earnings Yield
-16.86%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$492.29M
Shares Outstanding
90.49M
Volume
100
Short Interest
0.00%
Avg. Volume
61.633
Financials (TTM)
Gross Profit
$21.44B
Operating Income
$8.28B
EBITDA
$3.91B
Operating Cash Flow
$2.67B
Capital Expenditure
$448.39M
Free Cash Flow
$3.12B
Cash & ST Invst.
$20.38B
Total Debt
$60.94B
Nxera Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$7.77B
+13.5%
Gross Profit
$5.72B
+21.1%
Gross Margin
73.58%
N/A
Market Cap
$492.29M
N/A
Market Cap/Employee
$1.27M
N/A
Employees
387
N/A
Net Income
$7.73B
-478.9%
EBITDA
$283.25M
+89.8%
Quarterly Fundamentals
Net Cash
$40.56B
-27.9%
Accounts Receivable
$10.47B
+56.4%
Inventory
$11.30B
+27.9%
Long Term Debt
$54.25B
-11.4%
Short Term Debt
$6.69B
-0.0%
Return on Assets
-9.30%
N/A
Return on Invested Capital
-7.05%
N/A
Free Cash Flow
$272.24M
+97.6%
Operating Cash Flow
$125.11M
+98.9%